US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Mangoceuticals Inc (MGRX)
Mangoceuticals Inc (MGRX) ニュース

MGRX

Mangoceuticals (MGRX)

Mangoceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MGRX

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	03 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/11	02 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	21 : 30	GlobeNewswire Inc.	MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/05	05 : 00	GlobeNewswire Inc.	MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies	NASDAQ:MGRX	Mangoceuticals Inc
2024/06/04	21 : 00	GlobeNewswire Inc.	MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/28	21 : 30	GlobeNewswire Inc.	Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/23	21 : 30	GlobeNewswire Inc.	MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/21	21 : 30	GlobeNewswire Inc.	MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/17	05 : 40	GlobeNewswire Inc.	MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/17	02 : 59	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/16	22 : 19	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/16	05 : 52	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/14	22 : 00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/10	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/07	06 : 32	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/07	05 : 43	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:MGRX	Mangoceuticals Inc
2024/05/02	21 : 00	GlobeNewswire Inc.	Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement	NASDAQ:MGRX	Mangoceuticals Inc
2024/04/25	21 : 30	GlobeNewswire Inc.	Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care	NASDAQ:MGRX	Mangoceuticals Inc
2024/04/12	21 : 45	GlobeNewswire Inc.	Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products	NASDAQ:MGRX	Mangoceuticals Inc
2024/03/12	22 : 00	GlobeNewswire Inc.	MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/20	23 : 00	GlobeNewswire Inc.	MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/13	22 : 00	GlobeNewswire Inc.	MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/06	23 : 00	GlobeNewswire Inc.	MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS	NASDAQ:MGRX	Mangoceuticals Inc
2024/02/05	22 : 50	GlobeNewswire Inc.	MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product	NASDAQ:MGRX	Mangoceuticals Inc
2024/01/19	22 : 00	GlobeNewswire Inc.	MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11	NASDAQ:MGRX	Mangoceuticals Inc
2023/12/16	00 : 39	GlobeNewswire Inc.	Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering	NASDAQ:MGRX	Mangoceuticals Inc
2023/12/13	21 : 30	GlobeNewswire Inc.	MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT	NASDAQ:MGRX	Mangoceuticals Inc

Showing the most relevant articles for your search:NASDAQ:MGRX

Ankr Eth2 Reward Bearing Certifi

Host Hotels and Resorts

Mitsu Hc Cap.23

The Navigator Company Na...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約